Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Jun 1;37(2):117-120.
eCollection 2018 Jun.

Novel mosaic mutation in the dystrophin gene causing distal asymmetric muscle weakness of the upper limbs and dilated cardiomyopathy

Affiliations
Case Reports

Novel mosaic mutation in the dystrophin gene causing distal asymmetric muscle weakness of the upper limbs and dilated cardiomyopathy

Joana Ribeiro et al. Acta Myol. .

Abstract

A group of heterogeneous muscle diseases are caused by dystrophin gene (DMD) mutations. We hereby present a male patient with a diagnosis of symptomatic dilated cardiomyopathy at 44 years-old who developed, soon after, weakness of distal right upper limb. At the age of 58, neurological examination revealed severe atrophy of right thenar muscles, flexion contractures on the right elbow, wrist and fingers, bilateral calf hypertrophy, myotatic areflexia in the upper limbs and hyporeflexia in the lower limbs. Manual muscle examination showed distal weakness of right upper limb muscles, severe on abductor pollicis brevis and extensor pollicis longus, and milder on interossei, finger extensors and brachioradialis muscles. Further testing revealed CK of 1500 U/L, a myopathic pattern on electromyography, and myopathic changes on right deltoid muscle biopsy, with immunohistochemistry showing focal sub-expression of dystrophin. Cardiac workup revealed a severe reduction in left ventricular ejection fraction, with a left ventricle of increased dimensions and global hypo-contractibility. A next-generation sequencing based panel for muscular diseases was performed and a nonsense mutation (c.C7525T) was identified in exon 51 of DMD gene, present in 70% of the gene readings (consistent with mosaicism).

Keywords: dilated cardiomyopathy; dystrophin gene; next generation sequencing.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Atrophy of the right thenar eminence (arrow) and flexion contracture of the right elbow (A); Flexion contractures of the right wrist and fingers (B); Calf hypertrophy (C).
Figure 2.
Figure 2.
Deltoid muscle biopsy. Increased variability in fibre size and rare necrotic fibres (H&E - 200x) (A, B); Immunohistochemical staining for Dys3 showing focal sub-expression of dystrophin (200x) (C).
Figure 3.
Figure 3.
IGV image showing the variant found in the patient. Of the 555 reads reached for this nucleotide, 70% are carriers of the nonsense allele while 30% are carriers of the wild type allele.

References

    1. Brandsema JF, Darras BT. Dystrophinopathies. Semin Neurol 2015. 35:369-84. - PubMed
    1. Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2003;2:731-40. - PubMed
    1. Amato AA, Griggs RC. Overview of the muscular dystrophies. Handb Clin Neurol 2011;101:1-9. - PubMed
    1. Ferlini A, Neri M, Gualandi F. The medical genetics of dystrophinopathies: molecular genetic diagnosis and its impact on clinical practice. Neuromuscular Disorders 2013;23:4-14. - PubMed
    1. Hoogerwaard EM, Bakker E, Ippel PF. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study. Lancet 1999;353:2116-9. - PubMed

Publication types

LinkOut - more resources